Cargando…
Sugammadex-Associated Hypotension, Bradycardia, Asystole, and Death
On December 16, 2015, the Food and Drug Administration (FDA) in the United States approved sugammadex (Bridion, Merck and Co), a modified gamma-cyclodextrin, to be used as a reversal agent. It is a first and unique selective nondepolarizing steroidal muscle relaxant (NDSMR) binding agent with a grea...
Autores principales: | Mirza, Kazim, Landoski, Kathryn, Thakar, Dilip, Heir-Singh, Jagtar, Jackson, Timothy, Kassab, Cynthia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303763/ https://www.ncbi.nlm.nih.gov/pubmed/32566314 http://dx.doi.org/10.1155/2020/8767195 |
Ejemplares similares
-
Severe Hypotension, Bradycardia and Asystole after Sugammadex Administration in an Elderly Patient
por: Fierro, Carmen, et al.
Publicado: (2021) -
Severe bradycardia and asystole associated with sugammadex: case report
por: Oliveira, Catarina, et al.
Publicado: (2019) -
Sugammadex associated profound bradycardia and sustained hypotension
por: Choi, Jae Moon, et al.
Publicado: (2020) -
Comment on Fierro et al. Severe Hypotension, Bradycardia and Asystole after Sugammadex Administration in an Elderly Patient. Medicina 2021, 57, 79
por: Sagliocco, Orlando, et al.
Publicado: (2022) -
Sugammadex induced bradycardia and hypotension: A case report and literature review
por: Teng, I-Chia, et al.
Publicado: (2021)